Related Experiment Videos
Fetal pituitary negative feedback at early gestational age
1Paediatric Endocrine Unit, Ha'Emek Medical Centre, Afula, affiliated to the Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Clinical Endocrinology
|September 1, 1999
Summary
Early diagnosis and treatment of fetal Graves
Area of Science:
- Endocrinology
- Maternal-Fetal Medicine
- Neonatology
Background:
- Fetal Graves' disease, caused by maternal thyroid stimulating autoantibodies (TSAb), can lead to significant fetal complications.
- Early diagnosis and intervention are crucial for improving fetal outcomes.
Observation:
- Prenatal diagnosis of fetal thyrotoxicosis was achieved at 20 weeks gestation via umbilical cord sampling (UBS).
- Diagnosis was based on suppressed thyroid stimulating hormone (TSH) and elevated free thyroxine (FT4) levels.
- Maternal TSAb were identified as the cause of transplacental transfer leading to fetal hyperthyroidism.
Findings:
- Treatment with propylthiouracil (PTU) effectively improved fetal thyroid function and clinical signs.
- Persistent mild fetal hyperthyroidism was noted through serial UBS until delivery.
- Evidence of pituitary negative feedback was observed as early as 20 weeks gestation, indicated by undetectable fetal TSH with elevated FT4.
- Amniotic fluid TSH levels were found to be unreliable for predicting fetal thyroid status.
Implications:
- This case demonstrates the earliest documented intact fetal pituitary-thyroid feedback mechanism.
- Pituitary maturation may occur earlier in fetal development than previously understood.
- Successful prenatal management of fetal Graves' disease is achievable, highlighting the importance of early diagnosis and treatment.